help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JACOBS, B. R.
Right arrow Articles by SMITH, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JACOBS, B. R.
Right arrow Articles by SMITH, D. J.

Am. J. Respir. Crit. Care Med., Volume 158, Number 5, November 1998, 1536-1542

Aerosolized Soluble Nitric Oxide Donor Improves Oxygenation and Pulmonary Hypertension in Acute Lung Injury

BRIAN R. JACOBS, RICHARD J. BRILLI, EDGAR T. BALLARD, DANIEL J. PASSERINI, and DANIEL J. SMITH

Division of Critical Care Medicine and Department of Pathology, Children's Hospital Medical Center, Cincinnati; and Department of Chemistry, University of Akron, Akron, Ohio

Acute respiratory distress syndrome (ARDS) is a major cause of morbidity and mortality in critically ill patients. The associated ventilation/perfusion mismatch and pulmonary hypertension are amenable to treatment with inhaled nitric oxide (NO) gas. Compounds formed by reacting NO with various nucleophiles (NONOates) release NO spontaneously and induce vasodilation. Intratracheally administered NONOates result in selective reduction in pulmonary hypertension. We hypothesized that a nebulized NONOate would improve oxygenation and reduce pulmonary vascular resistance in oleic acid-induced acute lung injury and pulmonary hypertension. Pigs underwent catheterization of the pulmonary artery, left atrium, and right atrium, and a flow probe was positioned around the pulmonary artery. Acute lung injury and pulmonary hypertension were induced with intravenous oleic acid. Animals were randomly assigned to receive either nebulized saline or the NONOate 2-(dimethylamino)ethylputreanine/NO (DMAEP/NO). Hemodynamic, gas exchange, pulmonary function, methemoglobin, and nitrite/nitrate measurements were obtained for 60 min. Animals in the DMAEP/NO group had improvement in PaO2 as compared with control animals (from 139 ± 19 mm Hg to 180 ± 19 mm Hg in the DMAEP/NO group [n = 6]; and from 144 ± 6 mm Hg to 150 ± 9 mm Hg in the saline group [n = 6], p < 0.05). After aerosol treatment, animals in the DMAEP/NO group had a greater reduction in pulmonary vascular resistance index (PVRI) than did control animals (from 81 ± 17 dyne · s/cm5/kg to 34 ± 8 dyne · s/cm5/kg; and from 104 ± 16 dyne · s/cm5/kg to 64 ± 11 dyne · sec/cm5/ kg in the saline group at 60 min, p < 0.05). There were no differences between the groups in systemic vascular resistance index (SVRI), cardiac index (CI), methemoglobin, nitrite/nitrate, or lung pathology scores. We conclude that DMAEP/NO improves oxygenation and has selective pulmonary vasodilating properties without causing significant systemic toxicity in this porcine model of acute lung injury.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
B. M. Tsai, M. Wang, M. W. Turrentine, Y. Mahomed, J. W. Brown, and D. R. Meldrum
Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basic mechanisms to potential therapies
Ann. Thorac. Surg., July 1, 2004; 78(1): 360 - 368.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
T. Wang, D. El Kebir, and G. Blaise
Inhaled nitric oxide in 2003: a review of its mechanisms of action: [L'inhalation de monoxyde d'azote en 2003 : une revue de ses mecanismes et de son action]
Can J Anesth, October 1, 2003; 50(8): 839 - 846.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. Sokol, S. E. Jacobs, and D. Bohn
Inhaled Nitric Oxide for Acute Hypoxic Respiratory Failure in Children and Adults: A Meta-analysis
Anesth. Analg., October 1, 2003; 97(4): 989 - 998.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. F. Lam, P. V. van Heerden, K. F. Ilett, P. Caterina, and P. Filion
Two Aerosolized Nitric Oxide Adducts as Selective Pulmonary Vasodilators for Acute Pulmonary Hypertension
Chest, March 1, 2003; 123(3): 869 - 874.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. M. Dukelow, S. Weicker, T. A. Karachi, H. M. Razavi, D. G. McCormack, M. G. Joseph, and S. Mehta
Effects of Nebulized Diethylenetetraamine-NONOate in a Mouse Model of Acute Pseudomonas aeruginosa Pneumonia
Chest, December 1, 2002; 122(6): 2127 - 2136.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Y. Kirov, O. V. Evgenov, V. N. Kuklin, L. Virag, P. Pacher, G. J. Southan, A. L. Salzman, C. Szabo, and L. J. Bjertnaes
Aerosolized Linear Polyethylenimine-Nitric Oxide/Nucleophile Adduct Attenuates Endotoxin-induced Lung Injury in Sheep
Am. J. Respir. Crit. Care Med., December 1, 2002; 166(11): 1436 - 1442.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
T. L. Gluckman, J. E. Grossman, J. D. Folts, and K. T. Kruse-Elliott
Modulation of endotoxin-induced cardiopulmonary dysfunction by S-nitroso-albumin
Innate Immunity, February 1, 2002; 8(1): 17 - 26.
[Abstract] [PDF]

Home page
 Circ. Res.Home page
L. J. Ignarro, C. Napoli, and J. Loscalzo
Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric Oxide: An Overview
Circ. Res., January 11, 2002; 90(1): 21 - 28.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. A. Adams, M. J. Mangino, J. Bassuk, and M. A. Sackner
Hemodynamic effects of periodic Gz acceleration in meconium aspiration in pigs
J Appl Physiol, December 1, 2000; 89(6): 2447 - 2452.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society